Galizio M, Journey J W, Royal S A, Welker J A
Department of Psychology, University of North Carolina, Wilmington 28403.
Pharmacol Biochem Behav. 1990 Oct;37(2):235-8. doi: 10.1016/0091-3057(90)90327-e.
Concurrent performances were studied in rats under conditions where responses on one lever postponed shock on a Sidman avoidance schedule and responses on another lever produced periods of signaled timeout from avoidance on a variable-interval schedule. Chlorpromazine decreased rates of responding on both the timeout and avoidance levels to about the same extent. The effects of chlordiazepoxide and CGS 9896 depended upon the event maintaining responding. Both drugs increased responding on the timeout lever at doses that concurrently decreased responding on the avoidance lever. Thus, the novel anxiolytic CGS 9896 produced effects that closely resembled those of the benzodiazepine anxiolytic, chlordiazepoxide. Like chlorpromazine, buspirone decreased both avoidance and timeout responding. Despite the documented anxiolytic properties of buspirone, its actions here were unlike those of the other anxiolytic drugs tested. Nonetheless, the differentiation between drugs obtained with the timeout from avoidance procedure indicates its utility for behavioral pharmacology.
在大鼠身上研究了同时进行的行为表现,实验条件如下:在一个斯德曼回避程序中,对一个杠杆的反应可推迟电击;在一个可变间隔程序中,对另一个杠杆的反应可产生有信号提示的回避超时阶段。氯丙嗪在大致相同程度上降低了超时阶段和回避阶段的反应速率。氯氮卓和CGS 9896的作用取决于维持反应的事件。两种药物在降低回避杠杆反应的同时,却增加了超时杠杆上的反应。因此,新型抗焦虑药CGS 9896产生的效果与苯二氮卓类抗焦虑药氯氮卓非常相似。与氯丙嗪一样,丁螺环酮降低了回避反应和超时反应。尽管丁螺环酮具有已被证实的抗焦虑特性,但其在此处的作用与所测试的其他抗焦虑药物不同。尽管如此,通过回避程序中的超时阶段所获得的药物间差异表明其在行为药理学中的效用。